Tempest Therapeutics Inc Share Price (NASDAQ: TPST)

Tempest Therapeutics Inc Stock Performance

as on October 14, 2025 at 1:29 am IST

Day's Low
Day's High
$10.3
Day's Price Range
$11.49
$11.51
10.51%
Downside
-0.17%
Upside
52 Week's Low
52 Week's High
$5.35
52-Week Price Range
$20.67
$11.51
53.52%
Downside
79.58%
Upside

Tempest Therapeutics Inc share price movements today

Previous Close: $10.27
Open: $10.35
Volume: 258.8K
Day's Low - High: $10.3 - $11.49
52 Week Low - High: $5.35 - $20.67

Tempest Therapeutics Inc Historical Returns

1 Month Return: + 12.43 %
3 Month Return: + 67.1 %
1 Year Return: -17.11 %
3 Year Return: -44.22 %
5 Year Return: 0 %

Tempest Therapeutics Inc Stock Fundamentals & Key Indicators

Check Tempest Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$45.6M

EPS (TTM)

-12.78

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-43.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

19410700.00%

Tempest Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tempest Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Tempest Therapeutics Inc	BUY	$45.6M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.3B	223.08%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.8B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$104.6B	50.07%	28.98	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.8B	-7.17%	14.23	31.37%

Stock Returns calculator for Tempest Therapeutics Inc Stock including INR - Dollar returns

The Tempest Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Tempest Therapeutics Inc investment value today

Current value as on today

₹88,514

Returns

₹11,486

(-11.49%)

Returns from Tempest Therapeutics Inc Stock

₹17,254 (-17.25%)

Dollar Returns*

₹5,768 (+5.77%)

Analyst Recommendation on Tempest Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Tempest Therapeutics Inc. Average target price of $9

Tempest Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Tempest Therapeutics Inc.

What analysts predicted

-27.89%DOWNSIDE

Target Price

Current Price

$11.51

Analyzed by

12 Analysts

Target

$9.00

Tempest Therapeutics Inc target price $9, a slight downside of -27.89% compared to current price of $11.51. According to 12 analysts rating.

Tempest Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Tempest Therapeutics Inc Stock has increased by 117% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 14, 2025 to October 14, 2025

Change:117% versus previous 30 day period

Tempest Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	0	0	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-7	-7	-6	-7	-7	-9	-10	-13	-10	-7
EBITDA	-6	-6	-5	-7	-7	-9	-10	-13	-10	-7
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-7	-6	-7	-7	-9	-10	-13	-10	-7
Income Tax Expense	0	0	0	0	0	-	-	0	-	-
Net Income	-7	-7	-6	-7	-7	-9	-10	-13	-10	-7
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-2842.18%	-2234.57%	0.00%

Tempest Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	-	-	-	-	-
Gross Profit	-1	-4	0	0	-1	-1	0	0
Operating Income	-71	-81	-20	-19	-26	-34	-29	-42
EBITDA	-71	-79	-84	-18	-25	-32	-28	-40
Interest Expense	0	0	-	0	1	1	1	1
Depreciation	-	-	-	0	0	0	0	0
Income Before Tax	-73	-82	-84	-19	-28	-35	-29	-41
Income Tax Expense	0	0	0	0	1	1	-	-41
Net Income	-73	-82	-84	-19	-28	-35	-29	-41
Net Profit Margin	-26432.85%	-12597.24%	-28670.51%	0.00%	0.00%	0.00%	0.00%	0.00%

Tempest Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-7	-6	-7	-7	-9	-10	-13	-10	-7
Operating Cash Flow	-6	-6	-6	-7	-5	-10	-10	-8	-8
Investing Cash Flow	0	-	0	0	0	0	0	-	-
Financing Cash Flow	1	0	34	0	4	1	17	0	1
Change in Cash	-5	-6	28	-6	-1	-9	7	-8	-7

Tempest Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-82	-84	-27	-44	-19	-28	-35	-29	-41
Operating Cash Flow	-61	-20	-23	-41	-19	-25	-31	-27	-33
Investing Cash Flow	8	0	1	3	0	0	0	0	0
Financing Cash Flow	54	-4	78	26	34	59	11	35	24
Change in Cash	0	-26	55	-9	15	33	-20	8	-8

Global Institutional Holdings in Tempest Therapeutics Inc

Funds	Holdings
Sabby Management LLC	6.23%
Versant Venture Management LLC	6.08%
TANG CAPITAL MANAGEMENT LLC	3.13%
Vanguard Group Inc	3.03%
BlackRock Inc	0.88%

See all

Insights on Tempest Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, TPST stock has moved up by 7.4%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 150.6% return, outperforming this stock by 194.8%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.1% return, outperforming this stock by 81.2%

About Tempest Therapeutics Inc

tempest therapeutics is a development-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways. tempest has a balanced and deep pipeline consisting of first-in-class and best-in-class small molecule therapeutics, which modulate distinct immune response pathways relevant to mounting an effective anti-tumor response. the molecules were developed by inception sciences, a versant ventures affiliated drug discovery engine. tempest has assembled a highly experienced team of small molecule and immuno-oncology drug developers to advance these programs to the clinic across diverse cancers representing significant unmet medical need. tempest is backed by a syndicate of leading us and china based venture capital firms.

Organisation	Tempest Therapeutics Inc
Headquarters	2000 Sierra Point Parkway, Brisbane, CA, United States, 94005
CEO	Mr. Stephen R. Brady J.D., LLM
E-voting on shares	Click here to vote

Key Management of Tempest Therapeutics Inc

Name	Title
Mr. Stephen R. Brady J.D., LLM	CEO, President & Director
Mr. Nicholas Maestas	CFO, Head of Corporate Strategy & Secretary
Dr. Samuel Whiting M.D., Ph.D.	Executive VP, Chief Medical Officer and Head of R&D
Mr. Justin Trojanowski CPA	Corporate Controller, Treasurer & Principal Accounting Officer
Ms. Lindsay Young	Head of Human Resources

FAQs

What is Tempest Therapeutics Inc share price today?

Tempest Therapeutics Inc share price today is $11.51 as on October 14, 2025 at 1:29 am IST at the close of the market. Tempest Therapeutics Inc share today touched a day high of $11.49 and a low of $10.3.

What is the 52 week high and 52 week low for Tempest Therapeutics Inc share?

Tempest Therapeutics Inc share touched a 52 week high of $20.67 on October 16, 2024 and a 52 week low of $5.35 on April 7, 2025. Tempest Therapeutics Inc stock price today i.e. October 14, 2025 at 1:29 am IST is closed at $11.51,which is 44.32% down from its 52 week high and 115.16% up from its 52 week low.

What is Tempest Therapeutics Inc's market capitalisation today?

Tempest Therapeutics Inc market capitalisation is $0.00T as on October 14, 2025 at 1:29 am IST.

How to invest in Tempest Therapeutics Inc Stock (TPST) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tempest Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tempest Therapeutics Inc Shares that will get you 0.1303 shares as per Tempest Therapeutics Inc share price of $11.51 per share as on October 14, 2025 at 1:29 am IST.

What is the minimum amount required to buy Tempest Therapeutics Inc Stock (TPST) from India?

Indian investors can start investing in Tempest Therapeutics Inc (TPST) shares with as little as ₹88.771 or $1 (as of October 14, 2025 at 5:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹887.71 in Tempest Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on October 14, 2025 at 5:42 pm IST). Based on Tempest Therapeutics Inc share’s latest price of $11.51 as on October 14, 2025 at 1:29 am IST, you will get 0.8688 shares of Tempest Therapeutics Inc. Learn more about fractional shares .